Helical β-Peptide Inhibitors of the p53-hDM2 Interaction
- 17 July 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 126 (31) , 9468-9469
- https://doi.org/10.1021/ja031625a
Abstract
HDM2 is recognized in vivo by a short α-helix within the p53 trans-activation domain (p53AD). Disruption of the p53·hDM2 interaction is an important goal for cancer therapy. A functional epitope comprised of three residues on one face of the p53AD helix (F19, W23, and L26) contributes heavily to the binding free energy. We hypothesized that the p53AD functional epitope would be recapitulated if the side chains of F19, W23, and L26 were presented at successive positions three residues apart on a stabilized β3-peptide 14-helix. Here, we report a set of β3-peptides that possess significant 14-helix structure in water; one recognizes a cleft on the surface of hDM2 with nanomolar affinity. The strategy for β3-peptide design that we describe is general and may have advantages over one in which individual or multiple β-amino acid substitutions are introduced into a functional α-peptide, because it is based on homology at the level of secondary structure, not primary sequence.Keywords
This publication has 25 references indexed in Scilit:
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- Molecular Recognition of Protein Surfaces: High Affinity Ligands for the CBP KIX DomainJournal of the American Chemical Society, 2003
- Helix Macrodipole Control of β3-Peptide 14-Helix Stability in WaterJournal of the American Chemical Society, 2003
- Study of the cytotoxic effect of a peptidic inhibitor of the p53–hdm2 interaction in tumor cellsFEBS Letters, 2002
- β-Peptides: From Structure to FunctionChemical Reviews, 2001
- Peptide Folding Induces High and Selective Affinity of a Linear and Small β-Peptide to the Human Somatostatin Receptor 4Journal of Medicinal Chemistry, 2001
- β-Amino Acid Scan of a Class I Major Histocompatibility Complex-restricted Alloreactive T-cell EpitopePublished by Elsevier ,2001
- The twists and turns of β‐peptidesChemical Biology & Drug Design, 1999
- Molecular characterization of the hdm2-p53 interaction 1 1Edited by J. KarnJournal of Molecular Biology, 1997
- Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation DomainScience, 1996